Related Experiment Video
Updated: Feb 7, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Antimicrobial Resistance in Escherichia coli
Laurent Poirel1,2,3, Jean-Yves Madec4, Agnese Lupo4
1Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.
Multidrug resistance in Escherichia coli is a global concern, driven by gene transfer. Veterinary antibiotic use may drive resistance, impacting human medicine.
Area of Science:
- Microbiology
- Antimicrobial Resistance
- Public Health
Background:
- Multidrug resistance in Escherichia coli is a significant global issue in both human and veterinary medicine.
- E. coli's capacity for accumulating resistance genes, primarily via horizontal gene transfer, exacerbates this problem.
Purpose of the Study:
- To review the problematic resistance mechanisms in E. coli.
- To discuss the role of veterinary medicine in the spread of antimicrobial resistance.
- To highlight the mechanisms of resistance gene dissemination.
Main Methods:
- Review of existing literature on E. coli multidrug resistance.
- Analysis of antimicrobial resistance mechanisms, including extended-spectrum beta-lactamases, carbapenemases, 16S rRNA methylases, PMQR, and mcr genes.
- Discussion of the role of mobile genetic elements like plasmids, transposons, and integrons.
Main Results:
- Problematic resistance mechanisms in E. coli include genes for extended-spectrum beta-lactamases, carbapenemases, 16S rRNA methylases, PMQR, and mcr genes.
- Colistin resistance in E. coli is linked to veterinary use, while carbapenemase spread is mainly in humans.
- E. coli from animals often exhibits resistance to older antimicrobials, and mobile genetic elements facilitate gene spread.
Conclusions:
- The dissemination of resistance genes in E. coli is significantly influenced by mobile genetic elements.
- Veterinary antimicrobial use can lead to coselection and persistence of resistance to critically important human medicines.
- Understanding these resistance dynamics is crucial for One Health approaches to combat antimicrobial resistance.
More Related Videos
08:32Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Resistivity
Resistance
Chemotaxis in E. coli
Stringent Response in E. coli